Literature DB >> 4109808

Genetic polymorphism in human glycine-rich beta-glycoprotein.

C A Alper, T Boenisch, L Watson.   

Abstract

Extensive polymorphism of glycine-rich beta-glycoprotein (GBG) was found in human sera. In all instances, GBG consisted of at least five components on electrophoresis. Patterns were such that they provided evidence for four alleles (at a locus designated Gb) which were expressed as autosomal codominant traits. Gb(S) and Gb(F) were found in all populations but with different frequencies, Gb(F1) was found in Negroes, and Gb(S1) was found in Caucasians. From electrophoretic studies of GBG, evidence was obtained that suggested that the GBG molecule was a tetramer consisting of A and B subunits in a proportion of about 1.6:1. The genetically controlled differences in GBG embodied in the Gb system indicated the presence of a third moiety of the molecule (C), possibly a polypeptide subunit. Electrophoretic studies of fragments from defined types of GBG suggested that GBG cleavage induced by complement or properdin activation in serum occurred through this C moiety, since two variants were detectable in one fragment and two were found in the other fragment. On comparison of fetal-maternal Gb types, approximately one-half the pairs showed differences. This indicated that GBG did not cross the placental barrier.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4109808      PMCID: PMC2139116          DOI: 10.1084/jem.135.1.68

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  18 in total

1.  Dissociation of lactate dehydrogenase into subunits with guanidine hydrochloride.

Authors:  E APPELLA; C L MARKERT
Journal:  Biochem Biophys Res Commun       Date:  1961-11-20       Impact factor: 3.575

2.  The properdin system and immunity. XIII. Assay and properties of a heat-labile serum factor (factor B) in the properdin system.

Authors:  L BLUM; L PILLEMER; I H LEPOW
Journal:  Z Immun exp ther       Date:  1959 Oct-Nov

3.  Immunofixation electrophoresis: a technique for the study of protein polymorphism.

Authors:  C A Alper; A M Johnson
Journal:  Vox Sang       Date:  1969-11       Impact factor: 2.144

4.  Functional relationship of factor B in the properdin system to C3 proactivator of human serum.

Authors:  I Goodkofsky; I H Lepow
Journal:  J Immunol       Date:  1971-10       Impact factor: 5.422

5.  Isolation and properties of a glycine-rich beta-glycoprotein of human serum.

Authors:  T Boenisch; C A Alper
Journal:  Biochim Biophys Acta       Date:  1970-12-22

6.  Isolation and properties of a glycine-rich gamma-glycoprotein of human serum.

Authors:  T Boenisch; C A Alper
Journal:  Biochim Biophys Acta       Date:  1970-07-27

7.  Inheritance of human alpha-1-acid glycoprotein (orosomucoid) variants.

Authors:  A M Johnson; K Schmid; C A Alper
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

8.  Genetic polymorphism of rhesus thyroxine-binding prealbumin: evidence for tetrameric structure in primates.

Authors:  C A Alper; N I Robin; S Refetoff
Journal:  Proc Natl Acad Sci U S A       Date:  1969-07       Impact factor: 11.205

9.  Polymorphism of monkey thyroxin-binding prealbumin (TBPA): mode of inheritance and hybridization.

Authors:  R S Bernstein; J Robbins; J E Rall
Journal:  Endocrinology       Date:  1970-02       Impact factor: 4.736

10.  Genetic polymorphism of the third component of human complement (C'3).

Authors:  C A Alper; R P Propp
Journal:  J Clin Invest       Date:  1968-09       Impact factor: 14.808

View more
  159 in total

1.  Apparently non-expressed alleles of factor B (BF) code for hypomorphic proteins.

Authors:  I Siemens; M Brenden; G Mauff; M Abbal; E Du Toit; J Bertrams; G Geserick
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Nomenclature for human complement factor B. WHO-IUIS Nomenclature Sub-Committee.

Authors: 
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

3.  A unique recombination event resulting in a C4A*Q0,C4B*Q0 double null haplotype.

Authors:  M B Fasano; J A Winkelstein; T LaRosa; W B Bias; R H McLean
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

4.  Genetic polymorphism of serum complement components in the chimpanzee.

Authors:  D Raum; H Balner; B H Petersen; C A Alper
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

Review 5.  Complement activation, regulation, and molecular basis for complement-related diseases.

Authors:  Goran Bajic; Søren E Degn; Steffen Thiel; Gregers R Andersen
Journal:  EMBO J       Date:  2015-10-21       Impact factor: 11.598

6.  Isolation of cDNA clones for the human complement protein factor B, a class III major histocompatibility complex gene product.

Authors:  D E Woods; A F Markham; A T Ricker; G Goldberger; H R Colten
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

7.  A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group.

Authors:  M Fennessy; K Metcalfe; G A Hitman; M Niven; P A Biro; J Tuomilehto; E Tuomilehto-Wolf
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

8.  Factors governing the human immune response to injected insulin.

Authors:  W G Reeves; D Barr; C A Douglas; K Gelsthorpe; I Hanning; A Skene; L Wells; R M Wilson; R B Tattersall
Journal:  Diabetologia       Date:  1984-04       Impact factor: 10.122

9.  HLA and complement allotypes in Type 1 (insulin-dependent) diabetes.

Authors:  J McCluskey; V J McCann; P H Kay; P J Zilko; F T Christiansen; G J O'Neill; R L Dawkins
Journal:  Diabetologia       Date:  1983-03       Impact factor: 10.122

10.  Extended major histocompatibility complex haplotypes in patients with gluten-sensitive enteropathy.

Authors:  C A Alper; E Fleischnick; Z Awdeh; A J Katz; E J Yunis
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.